Guilford, CT, United States of America

James N Livingston

USPTO Granted Patents = 5 


Average Co-Inventor Count = 15.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of James N Livingston

Introduction

James N Livingston is a notable inventor based in Guilford, CT (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Livingston has made strides in developing novel compounds that address critical health issues.

Latest Patents

Among his latest patents is the invention of indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and methods of preparation. This invention focuses on novel indane acetic acid derivatives that are beneficial in treating diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The patent also encompasses intermediates that are useful in the preparation of these derivatives and outlines methods for their synthesis.

Career Highlights

Throughout his career, Livingston has worked with prominent companies in the pharmaceutical industry, including Bayer Pharmaceuticals Corporation and Bayer Healthcare LLC. His work in these organizations has allowed him to contribute to the development of innovative solutions in healthcare.

Collaborations

Livingston has collaborated with esteemed colleagues such as Derek B Lowe and Philip L Wickens. These partnerships have fostered a creative environment that has led to the advancement of his research and inventions.

Conclusion

James N Livingston's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…